Clinical trial focus Target institutions with neurodegenerative research expertise and clinical trial capabilities to partner on MICRO-PD and NOSE-PD studies, leveraging their site networks for recruitment and data collection.

Small team agility Engage mid-size research organizations and contract research organizations (CROs) that value nimble collaboration, offering streamlined protocol handoffs, rapid study startup, and flexible budgeting to fit a smaller company footprint.

Funding signals Highlight opportunities from growing revenue in the $1–10M range as proof of commercial viability; propose collaboration models that align with modest budgets, such as shared IP, milestone-based payments, or sponsored research.

Technology leverage Offer scalable, cloud-based data management and collaboration tools compatible with Module Federation and Google Cloud to improve study coordination, patient data handling, and security compliance for trial sites.

Executive connections Map to potential partnerships with larger brain research institutes to expand capabilities, access broader patient pools, and co-develop translational research programs that align with their Parkinson's trial outputs.